Press Releases

WATERFORD, Irlanda, July 16, 2024 (GLOBE NEWSWIRE) — A Minimum Deposit Casinos (MDC), um dos principais recursos on-line para fãs de cassinos, tem o prazer de anunciar a conclusão bem-sucedida

LOS ANGELES, July 16, 2024 (GLOBE NEWSWIRE) — MGA Entertainment and Zapf Creation AG Complete Merger Forming MGA Zapf Creation GmbH LOS ANGELES; 16 July 2024 – MGA Entertainment, Inc.

Sabin Vaccine Institute Begins Phase 2 Clinical Trial for Sudan Ebolavirus Vaccine Laboratory at Makerere University Walter Reed Project, where Sabin’s Phase 2 Sudan ebolavirus vaccine clinical trial begins this

Philadelphia, Pennsylvania, July 15, 2024 (GLOBE NEWSWIRE) — LS Retail, an Aptos Company has partnered with FreedomPay, the world’s largest independent payment gateway. This partnership enables retail and hospitality businesses

Before and After: MDC Website Redesign Comparison of the Minimum Deposit Casinos website before and after the comprehensive redesign. The updated site features streamlined navigation, enhanced functionality, a modern aesthetic,

Nova instalação produzirá componentes de eletrólise e célula de combustível em apoio à transição energética global A produção deve ter início em meados de 2025 Investimento conjunto com outros parceiros

La nouvelle installation produira des composants pour l’électrolyse et les piles à combustible afin de soutenir la transition énergétique mondiale La production devrait commencer à l’été 2025 Investissement conjoint avec

Groundbreaking of new green hydrogen production facility in Budenheim, Germany Pictured left to right: Dr. Günter Krummel, Gesellschafter Trigona FCC; André Semann, CFO Budenheim; Meaghan McGuire, Head of Strategic Marketing,

CHINT Limitless super brand season SHANGHAI, July 10, 2024 (GLOBE NEWSWIRE) — CHINT is excited to announce the global launch of its “Limitless 2024 Cool Season” campaign, running from June

MARBURG, Germany, July 04, 2024 (GLOBE NEWSWIRE) — Global biotechnology leader CSL Behring (ASX: CSL) today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene